Simplex Trading
SKYE icon

Simplex Trading’s Skye Bioscience SKYE Stock Holding History

Simplex Trading’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Buy
+3,372
New +$21.2K ﹤0.01% 7169
2026
Q1 		– Sell
-791
Closed -$5.16K – 10376
2025
Q4 		$4.75K Buy
+791
New +$9.24K ﹤0.01% 7464
2025
Q3 		– Sell
-146
Closed -$4.41K – 10278
2025
Q2 		$4K Buy
+146
New +$2.42K ﹤0.01% 7917
2025
Q1 		– Sell
-2
Closed – – 9896
2024
Q4 		$0 Buy
+2
New +$67 ﹤0.01% 9828

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Simplex Trading's SKYE Position: Q2 2026 in Review

Simplex Trading opened a new position in Skye Bioscience (SKYE) in Q2 2026: 3,372 shares worth $18.7K. The stake represents ﹤0.01% of the portfolio and ranks #7169 among its holdings. This is a return to the name: Simplex Trading previously reported a position in SKYE as recently as Q4 2025.

Simplex Trading first reported a position in SKYE in Q4 2024 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Simplex Trading held 3,372 shares of Skye Bioscience worth $18.7K as of Q2 2026.
  • Skye Bioscience was a new Simplex Trading position in Q2 2026.
  • Skye Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7169 holding.
  • Simplex Trading first reported a position in Skye Bioscience in Q4 2024 and has held it in 4 quarters since.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.